The people behind the research: For Dr. Lebson, it's personal

December 2011
Momentum (19403410);Winter2011/2012, Vol. 5 Issue 1, p61
The article focuses on research scientist Lori Lebson, whose career as a multiple sclerosis (MS) treatment researcher was forged when her mom was diagnosed with MS. Lebson has decided to focus on finding new MS treatments, for her mother and for all people with the disease. It adds that Lebson single-handedly took the project from a concept to a therapeutic trial in mice, applying technologies in studying the role of an immune signaling molecule known as KLF4 in MS-like disease.


Related Articles

  • Harry Weaver Award fuels bright minds in MS research. Nauen, Elinor // Momentum (19403410);Summer2013, Vol. 6 Issue 3, p57 

    The article offers information about the Harry Weaver Neuroscience Scholar Award of the National MS Society. It says that the five-year career development grant, named after the Society's director of research from 1966-1977, is given to scientists with a promising future in MS research. It notes...

  • Scientific prize may turn wishes to reality. Uhland, Vicky // Momentum (19403410);Summer2013, Vol. 6 Issue 3, p29 

    The article reports on the contributions of couples Margery Barancik and Chuck Barancik, who were diagnosed with multiple sclerosis (MS) about 25 years ago, to the National MS Society's research portfolio. They have supported for the Society's acceleration of the MS drug development process....

  • Weaver awardees drive progress.  // Momentum (19403410);Summer2013, Vol. 6 Issue 3, p59 

    The article presents the recipients of the National MS Society Harry Weaver Neuroscience Scholar Award who earned The John Dystel Prize for Multiple Sclerosis Research. Doctor Richard M. Ransohoff of Cleveland Clinic Foundation has earned the 2012 John Dystel Prize for his work that led to new...

  • Ramping up rehab research. Coetzee, Timothy // Momentum (19403410);Winter2011/2012, Vol. 5 Issue 1, p63 

    The article discusses the innovative rehabilitation techniques that can help restore function in people with multiple sclerosis (MS). It explores the evidence that will convince doctors and insurers that rehabilitation of people with MS can help them achieve their physical, psychological, social...

  • Piecing the puzzle together. Weick, Rachel // Grand Rapids Business Journal;7/27/2015, Vol. 33 Issue 30, p1 

    The article offers information on medical research project Agent Z which aims to cure the autoimmune diseases multiple sclerosis.

  • Advocacy at work.  // Inside MS;Spring98, Vol. 16 Issue 1, p37 

    Reports on developments concerning the National Multiple Sclerosis Society's efforts to gain federal support for multiple sclerosis research programs in the United States as of March 1998. Work done with the Orphan Drug Tax Credit Coalition for drug research; Increase in funding for the...

  • More data on exercise for fatigue.  // Inside MS;Oct-Dec2003, Vol. 21 Issue 4, p38 

    Reports on a study conducted by researchers in Portland, Oregon regarding the effects of exercise on levels of fatigue in people with multiple sclerosis. Highlights of the study; Results of the experiments conducted.

  • Society research: More than test tubes. Coetzee, Timothy // Momentum (19403410);Winter2012/2013, Vol. 6 Issue 1, p62 

    The article discusses the comprehensive approach reinforced by the National Multiple Sclerosis (MS) Society towards the research on MS. The Health Care Delivery and Policy Research (HCDPR) program of the Society is highlighted which funds research projects that help in understanding the impact...

  • Towards a European Network for Multiple Sclerosis Trials (ENMST). Kappos, L; Polman, C; Thompson, AJ; Duda, P; Clanet, M; Comi, G; Hartung, HP; Montalban, X // Multiple Sclerosis (13524585);Dec2003, Vol. 9 Issue 6, p627 

    Quality standards for clinical studies in the field of multiple sclerosis (MS) have improved significantly, to the great benefit of patients. This development has been accompanied by soaring costs and ever increasing complexity, with industry-independent trials having become virtually...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics